Literature DB >> 24769795

Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.

Fei Yang1, Yinxiang Wei2, Zhijian Cai2, Lei Yu2, Lingling Jiang2, Chengyan Zhang2, Huanmiao Yan2, Qingqing Wang2, Xuetao Cao3, Tingbo Liang4, Jianli Wang2.   

Abstract

The Fas/FasL system transmits intracellular apoptotic signaling, inducing cell apoptosis. However, Fas signaling also exerts non-apoptotic functions in addition to inducing tumor cell apoptosis. For example, Fas signaling induces lung cancer tumor cells to produce prostaglandin E2 (PGE2) and recruit myeloid-derived suppressor cells (MDSCs). Activated cytotoxic T lymphocytes (CTLs) induce and express high levels of FasL, but the effects of Fas activation initiated by FasL in CTLs on apoptosis-resistant tumor cells remain largely unclear. We purified activated CD8(+) T cells from OT-1 mice, evaluated the regulatory effects of Fas activation on tumor cell escape and investigated the relevant mechanisms. We found that CTLs induced tumor cells to secrete PGE2 and increase tumor cell-mediated chemoattraction of MDSCs via Fas signaling, which was favorable to tumor growth. Our results indicate that CTLs may participate in the tumor immune evasion process. To the best of our knowledge, this is a novel mechanism by which CTLs play a role in tumor escape. Our findings implicate a strategy to enhance the antitumor immune response via reduction of negative immune responses to tumors promoted by CTLs through Fas signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24769795      PMCID: PMC4654365          DOI: 10.1038/cmi.2014.21

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  48 in total

1.  Stimulation of FasL induces production of proinflammatory mediators through activation of mitogen-activated protein kinases and nuclear factor-κB in THP-1 cells.

Authors:  Sang-Min Lee; Eun-Ju Kim; Kyoungho Suk; Won-Ha Lee
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

Authors:  L B Owen-Schaub; R Radinsky; E Kruzel; K Berry; S Yonehara
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

3.  Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs.

Authors:  R Yang; D Xu; A Zhang; A Gruber
Journal:  Int J Cancer       Date:  2001-11-01       Impact factor: 7.396

4.  Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent.

Authors:  Mobolaji O Olurinde; Ching-Hung Shen; Adam Drake; Ailin Bai; Jianzhu Chen
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

5.  Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.

Authors:  M Hishii; J T Kurnick; T Ramirez-Montagut; F Pandolfi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 6.  Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship.

Authors:  Ngozi R Monu; Alan B Frey
Journal:  Immunol Invest       Date:  2012       Impact factor: 3.657

7.  Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.

Authors:  Yufeng Xie; Haifeng Zhang; Wei Li; Yulin Deng; Manjunatha Ankathatti Munegowda; Rajni Chibbar; Mabood Qureshi; Jim Xiang
Journal:  J Immunol       Date:  2010-09-29       Impact factor: 5.422

8.  Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.

Authors:  Hanchen Li; Xueli Fan; Calin Stoicov; Jian Hua Liu; Sharif Zubair; Elena Tsai; Ronald Ste Marie; Timothy C Wang; Stephen Lyle; Evelyn Kurt-Jones; Jeanmarie Houghton
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

9.  COX2 regulation of breast cancer bone metastasis.

Authors:  John Karavitis; Ming Zhang
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

10.  Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases.

Authors:  F Toyoshima; T Moriguchi; E Nishida
Journal:  J Cell Biol       Date:  1997-11-17       Impact factor: 10.539

View more
  9 in total

1.  Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition.

Authors:  Chandra C Ghosh; Kara R Heatherton; Kyle P O' Connell; Ian S Alexander; Deborah A Greer; Jason LaPorte; Prajna Guha; Bryan F Cox; Steven C Katz
Journal:  Cancer Gene Ther       Date:  2022-06-14       Impact factor: 5.987

2.  Tumor immunotherapy: New aspects of natural killer cells.

Authors:  Yangxi Li; Rui Sun
Journal:  Chin J Cancer Res       Date:  2018-04       Impact factor: 5.087

3.  Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.

Authors:  Luya Cai; Xuedan Du; Cheng Zhang; Shanshan Yu; Lixiao Liu; Jinduo Zhao; Ye Zhao; Chunhong Zhang; Jinting Wu; Bin Wang; Yingyu Chen; Xiaoping Su; Xiaojian Yan; Wenfeng Li
Journal:  Cancer Immunol Immunother       Date:  2021-11-03       Impact factor: 6.630

4.  Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma.

Authors:  Tiziana Annese; Giuseppe Ingravallo; Roberto Tamma; Michelina De Giorgis; Eugenio Maiorano; Tommasina Perrone; Francesco Albano; Giorgina Specchia; Domenico Ribatti
Journal:  Transl Oncol       Date:  2020-02-29       Impact factor: 4.243

5.  Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma.

Authors:  Karine Araújo Damasceno; Aline Michelle Dos Santos-Conceição; Laís Pereira Silva; Thiago Marconi de Souza Cardoso; Carlos Humberto da Costa Vieira-Filho; Samantha Hellen Santos Figuerêdo; Emanoel Martins-Filho; Barbra Gabriela Oliveira de Faria; João Moreira da Costa-Neto; Geovanni Dantas Cassali; Alessandra Estrela-Lima
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

6.  Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer.

Authors:  Sara D Johnson; M Rita I Young
Journal:  Front Immunol       Date:  2016-09-22       Impact factor: 7.561

7.  Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma.

Authors:  Yangyang Liu; Yue Hu; Feifei Gu; Jinyan Liang; Yulan Zeng; Xiaohua Hong; Kai Zhang; Li Liu
Journal:  Oncotarget       Date:  2017-06-28

Review 8.  The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.

Authors:  Giuseppe Ingravallo; Roberto Tamma; Giuseppina Opinto; Tiziana Annese; Francesco Gaudio; Giorgina Specchia; Tommasina Perrone; Pellegrino Musto; Gerardo Cazzato; Emilio Bellitti; Saverio Capodiferro; Eugenio Maiorano; Domenico Ribatti
Journal:  Diagnostics (Basel)       Date:  2022-02-23

9.  Simultaneous silencing of lysophosphatidylcholine acyltransferases 1-4 by nucleic acid nanoparticles (NANPs) improves radiation response of melanoma cells.

Authors:  Renata F Saito; Maria Cristina Rangel; Justin R Halman; Morgan Chandler; Luciana Nogueira de Sousa Andrade; Silvina Odete-Bustos; Tatiane Katsue Furuya; Alexis Germán Murillo Carrasco; Adriano B Chaves-Filho; Marcos Y Yoshinaga; Sayuri Miyamoto; Kirill A Afonin; Roger Chammas
Journal:  Nanomedicine       Date:  2021-06-24       Impact factor: 6.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.